These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 9486100)

  • 21. Docetaxel alternating with epirubicin and cyclophosphamide: a feasibility study in breast cancer patients.
    ten Bokkel Huinink WW; Lustig V; Dubbelman R; Hiemstra A; Rodenhuis S
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S23-5. PubMed ID: 9486100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of docetaxel/doxorubicin combination in metastatic breast cancer.
    Diéras V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):31-3. PubMed ID: 9364539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel in combination chemotherapy for metastatic breast cancer.
    Khayat D; Antoine E
    Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.
    Tolcher AW
    Semin Oncol; 1996 Feb; 23(1 Suppl 1):37-43. PubMed ID: 8629035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel and epirubicin in advanced breast cancer.
    Sessa C; Pagani O
    Oncologist; 2001; 6 Suppl 3():13-6. PubMed ID: 11346679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Docetaxel (Taxotere) in combination with anthracycline, capecitabin (Xeloda) and new drugs].
    Galligioni E
    Tumori; 2001; 87(1 Suppl 2):S1-9. PubMed ID: 11357871
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.